Skip to content
Ultrapath

Zimbabwe Rejects ‘Unbalanced’ US Health Aid Deal Due to Information Concerns

Medical funding illustration
The proposed American financial assistance was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has declined a major American health deal worth $367m (£272m) over five years over Washington's request for sensitive information.

This rejection was revealed after a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "lopsided".

An official representative has since explained that the US was demanding access to biological samples for scientific study and commercial gain but was not willing to guarantee the benefits from future medical innovations.

"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has appealed for continued dialogue to reach a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.

Broader Implications

Zimbabwe's decision comes after a similar situation in Kenya, where a court halted a similar deal with the US after legal challenges were raised about the security of citizens' health data.

Since resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had administered aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government deals to boost openness and accountability.

Based on statements, 16 nations in Africa have so far agreed to these new health pacts, representing over $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this partnership might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy via US-supported initiatives," Tremont commented.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"Put simply, our country would provide the basic resources for scientific discovery with no certainty that the end products would be accessible to our population should a future health crisis arise."

Sovereignty and Global Health

Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting systems already established via the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.

"This system is intended to ensure that when a nation contributes its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."

These objections over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We encourage ongoing discussions with our US partners on how subsequent collaboration might be arranged in a way that honours the sovereignty and dignity of each country."

Health Experts Reaction

A leading public health body expressed it understood the government's concerns, but urged that negotiations need to persist given that much of the nation's HIV programmes were funded by foreign aid.

"Where specific concerns arise, such as those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," the group commented.

The situation highlights the ongoing debate between accepting crucial international aid and safeguarding a country's data in an ever more data-driven world.

The writer

Carrie Phillips

A tech journalist and futurist passionate about AI ethics and sustainable innovation, with over a decade of industry experience.

Ultrapath

Type to search articles.